Tatva Chintan Pharma Chem Ltd share price logo

Tatva Chintan Pharma Chem Ltd

NSE: TATVA

BSE: 543321

Small Cap

Chemical Sector

Petrochemical Sector

₹1618.90

+71.60

(+4.63%)

as on

bell
The current prices are delayed by 15 mins, login to check live prices.

Tech Chart

What are INDmoney investors doing with Tatva Chintan Pharma Chem shares?

Based on platform-user behaviour - not analyst opinion or company fundamentals.

Search interest on INDmoney

-70%

Searches for Tatva Chintan Pharma Chem on INDmoney have decreased by 70% over the last 30 days.

Average holding period of indmoney investors

34 days

INDmoney investors hold Tatva Chintan Pharma Chem shares for an average of 34 days.

Key Events for Tatva Chintan Pharma Chem

Last Dividend Declared

₹2.00 per share, declared on 16/05/2026

View Dividend History

Tatva Chintan Pharma Chem Stock Performance

as on September 16, 2026 at 7:47 pm IST

  • Day's Low

    Day's High

    ₹1,520.00
    ₹1,637.80
    downward going graph

    6.11%

    Downside

    1.17%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    ₹981.50
    ₹1,838.10
    downward going graph

    39.37%

    Downside

    13.54%

    Upside

    downward going graph

Tatva Chintan Pharma Chem share price movements today

Previous Close
₹1,547.30
Open
₹1,618.90
Volume
80.54K
Upper Circuit
₹1,856.70
Lower Circuit
₹1,237.90
Day's Low - High
₹1,520.00 - ₹1,637.80
52 Week Low - High
₹981.50 - ₹1,838.10

Tatva Chintan Pharma Chem Historical Returns

1 Month Return
-8.22 %
3 Month Return
+ 30.47 %
1 Year Return
+ 40.38 %
3 Year Return
-5.67 %
5 Year Return
-29.12 %

Tatva Chintan Pharma Chem Fundamentals

as on September 16, 2026 at 2:17 pm IST

Market Cap

₹3,619.45 Cr

Return on Equity (ROE)

5.28

PE Ratio (TTM)

73.22

Return on capital employed (ROCE)

6.84

Industry PE ratio

49.57

Beta (LTM)

1.26

P/B Ratio

3.24

Dividend Yield

0.19

PEG Ratio

3.87

Quarterly Earnings Growth YOY

140.3

EPS (TTM)

17.98

Book Value

334.2

Tatva Chintan Pharma Chem Stock Valuation

as on September 16, 2026 at 2:17 pm IST

Tatva Chintan Pharma Chem in the last 5 years

  • Overview

  • Trends

Lowest (44.37x)

October 20, 2021

Industry (49.57x)

September 11, 2026

Today (73.22x)

September 11, 2026

Highest (399.67x)

June 9, 2025

LowHigh

Today’s Price to Earnings Ratio: 73.22x

Tatva Chintan Pharma Chem Technical Analysis

Track how Tatva Chintan Pharma Chem technical analysis has moved over time to understand its trends.

1 min
5 min
15 min
30 min
1 day
1 week
1 month

Technicals Summary

Bearish

Neutral

Bullish

Bullish

Moving Averages

Bearish

Neutral

Bullish

Bullish

Oscillators

Bearish

Neutral

Bullish

Bullish

Overall

Bearish2
Bullish13
Neutral

Oscillators

Name

Value

Action

MACD level (12,26)
3.67
Bullish
CCI (20)
-336.19
Bullish
RSI (14)
75.26
Bearish
Momentum (10)
11.4
Bearish
ADI (14)
34.88
Bullish
Ultimate Oscillator (7,14,28)
90.92
Bullish

Moving Averages

Name

Value

Action

SMA (20)
1620.01
Bullish
EMA (20)
1621
Bullish
VWMA (20)
1622.54
Bullish
SMA (50)
1616.05
Bullish
EMA (50)
1617.66
Bullish
SMA (200)
1615.79
Bullish
EMA (200)
1612.15
Bullish
KAMA (200)
1615.62
Bullish
DEMA (200)
1620.7
Bullish

Tatva Chintan Pharma Chem Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Tatva Chintan Pharma Chem with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
Tatva Chintan Pharma Chem Ltd image
Tatva Chintan Pharma Chem Ltd
BUY3,619.45-5.82%0.5742505
Dynemic Products Ltd image
Dynemic Products Ltd
NA283.29-11.79%0.6119378
Archit Organosys Ltd image
Archit Organosys Ltd
NA135.919.24%0.005125
Chemfab Alkalis Ltd image
Chemfab Alkalis Ltd
NA534.9226.37%0.63-4311
OCCL Ltd image
OCCL Ltd
NA757.4512.28%0.0047505
See all

Market expectation of Tatva Chintan Pharma Chem Stock

Common consensus of the market based on various publicly available news, publications,brokerage expectation and market data

BUY

66.67%

Buy

0.00%

Hold

33.33%

Sell

Tatva Chintan Pharma Chem Ltd Quarterly Profit & Loss

Figures in Rupees Crores

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Sales
96.67
84.21
98.27
105.46
83.49
85.9
107.86
116.86
123.52
131.33
134.14
167.06
Other Income
0.76
1.21
4.53
1.17
0.38
0.04
0.72
1.16
1.01
1.73
-0.35
2.78
Total Income
97.43
85.42
102.79
106.64
83.87
85.94
108.59
118.02
124.52
133.07
133.8
169.84
Expenses
76.42
73.21
82.66
92.85
77.9
78.84
98.91
99.53
101.3
105.85
106.02
136.08
Operating Profit
20.25
11
15.61
12.61
5.59
7.06
8.95
17.33
22.22
25.48
28.12
30.98
Operating Profit Margin %
20.95%
13.06%
15.88%
11.96%
6.7%
8.22%
8.3%
14.83%
17.99%
19.4%
20.96%
18.54%
Profit Before Interest, Tax and Depreciation
21
12.2
20.14
13.79
5.96
7.1
9.67
18.49
23.22
27.22
27.78
33.76
Interest
3.01
0.38
0.21
0.31
0.17
0.42
0.39
0.41
0.51
0.49
1.44
2.08
Depreciation
6.78
6.58
6.23
6.67
6.81
6.92
7.26
8.97
9.05
9.07
9.76
10.57
Profit Before Tax
11.21
5.24
13.7
6.81
-1.02
-0.24
2.02
9.11
13.66
17.66
16.58
21.11
Tax Paid
3.43
1.79
4.07
1.6
-0.35
-0.38
1
2.45
3.75
2.49
6.26
5.13
Profit After Tax
7.78
3.46
9.61
5.21
-0.66
0.14
1.03
6.65
9.92
15.17
10.32
15.98
Total Net profit including share of profit / Loss from associate company
7.78
3.46
9.61
5.21
-0.66
0.14
1.03
6.65
9.92
15.17
10.32
15.98
EPS
3.43
1.48
4.11
2.23
-0.29
0.06
0.44
2.84
4.24
6.49
4.41
6.83
Actual EPS
3.43
1.48
4.11
2.23
-0.29
0.06
0.44
2.84
4.24
6.49
4.41
6.83
Adjusted EPS
3.43
1.48
4.11
2.23
-0.29
0.06
0.44
2.84
4.24
6.49
4.41
6.83
Diluted EPS
3.43
1.48
4.11
2.23
-0.29
0.06
0.44
2.84
4.24
6.49
4.41
6.83

Tatva Chintan Pharma Chem Ltd Annual Profit & Loss

Figures in Rupees Crores

Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Mar 2026
Sales
206.31
263.24
300.36
433.65
423.61
393.5
382.71
505.86
Other Income
1.24
1.38
5.2
9.02
5.74
7.51
2.32
3.55
Total Income
207.55
264.62
305.56
442.66
429.36
401.01
385.03
509.41
Expenses
172.51
208.29
233.92
325.41
366.62
325.31
348.5
412.7
Operating Profit
33.8
54.95
66.44
108.24
56.99
68.19
34.21
93.16
Operating Profit Margin %
16.38%
20.87%
22.12%
24.96%
13.45%
17.33%
8.94%
18.42%
Profit Before Interest, Tax and Depreciation
35.05
56.34
71.64
117.25
62.74
75.71
36.53
96.71
Interest
3.63
3.95
4.21
4.95
8.4
6.53
1.29
2.85
Depreciation
4.02
4.79
6.73
8.18
9.56
25.61
27.66
36.85
Profit Before Tax
27.4
47.6
60.7
104.12
44.78
43.57
7.58
57.01
Tax Paid
6.85
9.81
8.43
8.25
-0.7
13.21
1.87
14.96
Profit After Tax
20.54
37.79
52.26
95.87
45.49
30.35
5.71
42.05
Total Net profit including share of profit / Loss from associate company
20.54
37.79
52.26
95.87
45.49
30.35
5.71
42.05
EPS
10.23
18.81
26.02
44.59
20.52
13.26
2.44
17.98
Actual EPS
10.23
18.81
26.02
44.59
20.52
13.26
2.44
17.98
Adjusted EPS
4.09
7.52
26.02
44.59
20.52
13.26
2.44
17.98
Diluted EPS
10.23
18.81
26.02
44.59
20.52
13.26
2.44
17.98

Tatva Chintan Pharma Chem Ltd Cash Flow

Figures in Rupees Crores

Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Mar 2026
Net Cash from Operating Activities
12.59
7.36
25.31
19.69
20.38
27.78
98.04
24.77
31.49
Cash Flow from Investing Activities
-30.16
-16.77
-40.17
-20.66
-196.81
-101.22
-120.63
-65.29
-116.02
Cash Flow from Financing Activities
7.34
17.4
9.96
-4.71
234.97
37.8
30.52
16.59
78.92
Net Cash Flow
-10.24
7.99
-4.92
-5.68
58.54
-35.65
7.94
-23.93
-5.61

Tatva Chintan Pharma Chem Stock Shareholding Pattern

Numbers in percentages

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Promoters
72.02%
72.02%
72.02%
72.02%
72.02%
72.02%
72.02%
72.02%
72.02%
72.02%
72.02%
DII
13.06%
12.84%
10.63%
6.82%
6.34%
5.46%
5.11%
3.86%
3.33%
2.99%
3.11%
FII
4.21%
3.65%
3.37%
3.33%
3.36%
3.3%
3.26%
3.39%
4.17%
3.82%
3.93%
Public
10.71%
11.49%
13.98%
17.82%
18.28%
19.22%
19.6%
20.73%
20.48%
21.17%
20.94%
Total Outstanding Shares
2,33,92,055
2,33,92,055
2,33,92,055
2,33,92,055
2,33,92,055
2,33,92,055
2,33,92,055
2,33,92,055
2,33,92,055
2,33,92,055
2,33,92,055
Total Shareholders
74,519
73,730
73,912
79,623
79,009
78,393
76,792
73,331
68,657
66,842
64,921

Mutual Funds Buying / Exiting Tatva Chintan Pharma Chem

Holdings as of 15 Sep 2026 · based on the latest SEBI-mandated portfolio disclosures

Mutual Funds Buying Tatva Chintan Pharma Chem

Sorted by largest increase in holding, month-over-month.

Fund Name

Value of Holding

Increase (MoM)

Holding %

WhiteOak Capital Pharma and Healthcare Fund Direct Growth

WhiteOak Capital Pharma and Healthcare Fund Direct Growth

₹3.49 Cr

₹1.24 Cr (+55.12%)

0.47%

Mutual Funds Exiting Tatva Chintan Pharma Chem

Sorted by largest decrease in holding, month-over-month.

No exiting activity data available right now

No exiting activity data available right now

Tatva Chintan Pharma Chem Corporate Actions

View detailed summary of the earnings and dividend history of Tatva Chintan Pharma Chem.

  • Tatva Chintan Pharma Chem Ltd Earnings Results

    Tatva Chintan Pharma Chem Ltd’s net profit jumped 140.3% since last year same period to ₹15.98Cr in the Q1 2026-2027. On a quarterly growth basis, Tatva Chintan Pharma Chem Ltd has generated 54.84% jump in its net profits since last 3-months.

    Read More about Earnings Results

  • Tatva Chintan Pharma Chem Ltd Dividends May,2026

    In the quarter ending March 2026, Tatva Chintan Pharma Chem Ltd has declared dividend of ₹2.00 per share on 16 May 2026 - translating a dividend yield of 0.12%.

    Read More about Dividends

Indices Featuring Tatva Chintan Pharma Chem Stock

Check stock indices that include Tatva Chintan Pharma Chem.

S&P BSE Commodities

₹8,286.01

+30.88 (▲0.37%)

Insights on Tatva Chintan Pharma Chem Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 8 quarters, 83.87 Cr → 169.84 Cr (in ₹), with an average increase of 9.2% per quarter

  • imgPOSITIVE IMPACT

    FII Holding Up

    img

    Foreign Institutions have increased holdings from 3.82% to 3.93% in Jun 2026 quarter

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 2 quarters, 10.32 Cr → 15.98 Cr (in ₹), with an average increase of 35.4% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Privi Speciality Chemicals Ltd has given 184.9% return, outperforming this stock by 190.6%

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 72.02% of holdings in Jun 2026 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Aether Industries Ltd has given 115.4% return, outperforming this stock by 75.0%

  • imgNEGATIVE IMPACT

    Retail Holding Down

    img

    Retail Investor have decreased holdings from 21.17% to 20.94% in Jun 2026 quarter

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 7 days, TATVA stock has moved down by -8.4%

  • imgNEGATIVE IMPACT

    MF Holding Down

    img

    Mutual Funds have decreased holdings from 2.87% to 2.79% in Jun 2026 quarter

About Tatva Chintan Pharma Chem Ltd

Tatva Chintan Pharma Chem Limited, previously known as Tatva Chintan Pharma Chem Private Limited, was incorporated in India in 1996 under the Companies Act 2013. Specialty chemical products such as agro intermediaries, specialty chemicals, quats and pharma chemicals are manufactured and sold by the company across the globe with over 1300 customers. The company offers cost and logistics advantage through its two world-class manufacturing facilities located in Dahej and Ankleshwar in Gujarat. These facilities have been granted ISO 9001:2015 certification, and facilitate imports and exports. Additionally, they have a quality control lab to ensure ultrapure grade certification and detect impurities up to a ppm level. In 2004, they obtained a licence from the FDA Gujarat for the Ankleshwar manufacturing plant. The company has a modern analytical development laboratory and an RD centre approved by the Department of Scientific and Industrial Research. During 2021, the company obtained a revenue of Rs. 3 billion, earned through the manufacture of PTC, Structure Directing Agents, Electrolyte Salts, Pharmaceutical and agrochemical intermediates and other specialty chemicals. During the same period, the bonus share issue increased the equity share capital from 8,035,000 to 12,052,500 and the Dahej facility expanded its working capacity with an increased reactor capacity of 280KL and 17 assembly lines.

Revenue: ₹167.06Cr as on June 2026 (Q1 FY27)
Net Profit: ₹15.98Cr as on June 2026 (Q1 FY27)
Listing date: 29 Jul, 2021
Chairperson Name: Chintan Nitinkumar Shah
OrganisationTatva Chintan Pharma Chem Ltd
HeadquartersVadodara
IndustryChemicals
CEOChintan Nitinkumar Shah
E-voting on sharesClick here to vote

FAQs

What is Tatva Chintan Pharma Chem share price today?

Tatva Chintan Pharma Chem share price today stands at ₹1618.9 as on . Tatva Chintan Pharma Chem share today touched a day high of ₹1637.8 and a low of ₹1520.

What is the 52 week high and 52 week low range for Tatva Chintan Pharma Chem share?

Tatva Chintan Pharma Chem touched a 52 week high of ₹1838.1 and a 52 week low of ₹981.5. Tatva Chintan Pharma Chem share price today i.e. is trending at ₹1618.9, which is -11.93% down from its 52 week high and 64.94% up from its 52 week low.

What is Tatva Chintan Pharma Chem's market capitalisation today?

Tatva Chintan Pharma Chem market capitalisation is ₹3,619.45 Cr as on .

How to buy Tatva Chintan Pharma Chem shares?

To buy Tatva Chintan Pharma Chem shares, you need to follow these steps:

  • Open a Demat account and Trading account on INDmoney
  • Fund your Trading account
  • Search for TATVA or Tatva Chintan Pharma Chem Ltd on the INDmoney app to check live prices of the stock
  • Click on Buy or SIP to place an order to invest in Tatva Chintan Pharma Chem shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

What is Tatva Chintan Pharma Chem trading volume today?

Tatva Chintan Pharma Chem trading volume is 80.54K as on . This means that 80.54K shares of Tatva Chintan Pharma Chem were bought and sold on the stock market during today's trading session.